tai zhou hua cheng yi xue tou zi ji tuan you xian gong si - Net Worth and Insider Trading

tai zhou hua cheng yi xue tou zi ji tuan you xian gong si Net Worth

The estimated net worth of tai zhou hua cheng yi xue tou zi ji tuan you xian gong si is at least $326 Million dollars as of 2025-07-24. tai zhou hua cheng yi xue tou zi ji tuan you xian gong si is the 2201 Interest of corporation controlled by you of Qyuns Therapeutics Co Ltd and owns about 17,634,000 shares of Qyuns Therapeutics Co Ltd (HKSE:02509) stock worth over $326 Million. Details can be seen in tai zhou hua cheng yi xue tou zi ji tuan you xian gong si's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that tai zhou hua cheng yi xue tou zi ji tuan you xian gong si has not made any transactions after 2025-07-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of tai zhou hua cheng yi xue tou zi ji tuan you xian gong si

tai zhou hua cheng yi xue tou zi ji tuan you xian gong si Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, tai zhou hua cheng yi xue tou zi ji tuan you xian gong si owns 1 companies in total, including Qyuns Therapeutics Co Ltd (HKSE:02509) .

Click here to see the complete history of tai zhou hua cheng yi xue tou zi ji tuan you xian gong si’s form 4 insider trades.

Insider Ownership Summary of tai zhou hua cheng yi xue tou zi ji tuan you xian gong si

Ticker	Company	Transaction Date	Type of Owner
HKSE:02509	Qyuns Therapeutics Co Ltd	2025-07-14

tai zhou hua cheng yi xue tou zi ji tuan you xian gong si Latest Holdings Summary

tai zhou hua cheng yi xue tou zi ji tuan you xian gong si currently owns a total of 1 stock. tai zhou hua cheng yi xue tou zi ji tuan you xian gong si owns 17,634,000 shares of Qyuns Therapeutics Co Ltd (HKSE:02509) as of July 3, 2025, with a value of $326 Million.

Latest Holdings of tai zhou hua cheng yi xue tou zi ji tuan you xian gong si

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02509	Qyuns Therapeutics Co Ltd	2025-07-03	17,634,000	18.50	326,229,000

Holding Weightings of tai zhou hua cheng yi xue tou zi ji tuan you xian gong si

tai zhou hua cheng yi xue tou zi ji tuan you xian gong si Form 4 Trading Tracker

According to the SEC Form 4 filings, tai zhou hua cheng yi xue tou zi ji tuan you xian gong si has made a total of 4 transactions in Qyuns Therapeutics Co Ltd (HKSE:02509) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Qyuns Therapeutics Co Ltd is the sale of 0 shares on July 3, 2025, which brought tai zhou hua cheng yi xue tou zi ji tuan you xian gong si around $0.

Insider Trading History of tai zhou hua cheng yi xue tou zi ji tuan you xian gong si

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

tai zhou hua cheng yi xue tou zi ji tuan you xian gong si Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

tai zhou hua cheng yi xue tou zi ji tuan you xian gong si Ownership Network

Ownership Network List of tai zhou hua cheng yi xue tou zi ji tuan you xian gong si

No Data

Ownership Network Relation of tai zhou hua cheng yi xue tou zi ji tuan you xian gong si

tai zhou hua cheng yi xue tou zi ji tuan you xian gong si Owned Company Details

What does Qyuns Therapeutics Co Ltd do?

Who are the key executives at Qyuns Therapeutics Co Ltd?

tai zhou hua cheng yi xue tou zi ji tuan you xian gong si is the of Qyuns Therapeutics Co Ltd. Other key executives at Qyuns Therapeutics Co Ltd include qing dao xin chen ke chuang shi ye you xian gong si , tai zhou hong tai jian kang tou zi guan li zhong xin you xian he huo , and bei jing hong tai tong chuang tou zi guan li you xian gong si .

Qyuns Therapeutics Co Ltd (HKSE:02509) Insider Trades Summary

Over the past 18 months, tai zhou hua cheng yi xue tou zi ji tuan you xian gong si made 4 insider transaction in Qyuns Therapeutics Co Ltd (HKSE:02509) with a net sale of 0. Other recent insider transactions involving Qyuns Therapeutics Co Ltd (HKSE:02509) include a net sale of 0 shares made by bei jing yuan da hua chuang tou zi you xian gong si , a net sale of 0 shares made by Hu Kaijun , and a net sale of 0 shares made by SHENG Xi Tai .

In summary, during the past 3 months, insiders sold 0 shares of Qyuns Therapeutics Co Ltd (HKSE:02509) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Qyuns Therapeutics Co Ltd (HKSE:02509) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Qyuns Therapeutics Co Ltd (HKSE:02509)'s detailed insider trading history can be found in Insider Trading Tracker table.

Qyuns Therapeutics Co Ltd Insider Transactions

No Available Data

tai zhou hua cheng yi xue tou zi ji tuan you xian gong si Mailing Address

Above is the net worth, insider trading, and ownership report for tai zhou hua cheng yi xue tou zi ji tuan you xian gong si. Currently GuruFocus does not have mailing address information for tai zhou hua cheng yi xue tou zi ji tuan you xian gong si.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.